Anthony Rosenberg

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anthony Rosenberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Therapeutics, Inc. Director Stock Option (Right to Buy) 38,513 12 Jun 2025 Direct

Insider Reports Filed by Anthony Rosenberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGEM Cullinan Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 16:12
CGEM Cullinan Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director 27 Jun 2024, 19:00
CGEM Cullinan Oncology, Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 17:57
CGEM Cullinan Oncology, Inc. 22 Jun 2022 1 $0 4 Director 23 Jun 2022, 18:16
CGEM Cullinan Oncology, Inc. 16 Sep 2021 1 $0 4 Director 25 Mar 2022, 19:34